Avaliv Therapeutics

Avaliv TherapeuticsAbout

4.1 7 Reviews
avaliv.com
Write a review

About company

Avaliv Therapeutics is a drug discovery company focused on the development of novel small molecule therapeutics targeting inflammation and fibrosis related disorders. Our lead program is a first-in-class small molecule inhibitor for lysosomal proteases as a novel therapeutic intervention for non-alcoholic steatohepatitis (NASH) via an unexplored mechanistic pathway.